Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 18”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06709014
What this trial is testing

Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

Who this might be right for
Early Alzheimers Disease
Annovis Bio Inc. 760
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Not applicableEnrolling By InvitationNCT02414178
What this trial is testing

F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)

Who this might be right for
Alzheimer Disease
Washington University School of Medicine 130
Large-scale testing (Phase 3)Study completedNCT01689233
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 800
Early research (Phase 1)Study completedNCT02031198
What this trial is testing

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Axon Neuroscience SE 25
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Not applicableStudy completedNCT01834716
What this trial is testing

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

Who this might be right for
Alzheimer's Disease Prevention
Mayo Clinic 16
Large-scale testing (Phase 3)Looking for participantsNCT07724132
What this trial is testing

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer Disease Dementia
University College, London 1,200
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Early research (Phase 1)Study completedNCT01565343
What this trial is testing

18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 25
Very early researchStudy completedNCT01565291
What this trial is testing

A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Large-scale testing (Phase 3)Study completedNCT01265394
What this trial is testing

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Who this might be right for
Healthy
GE Healthcare 218
Not applicableStudy completedNCT04726527
What this trial is testing

Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

Who this might be right for
Primary Progressive AphasiaAlzheimer DiseaseDementia
University of Chicago 48
Large-scale testing (Phase 3)WithdrawnNCT05124561
What this trial is testing

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

Who this might be right for
COVID-19
CanSino Biologics Inc.
Early research (Phase 1)Study completedNCT01009359
What this trial is testing

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 22
Not applicableStudy completedNCT01550549
What this trial is testing

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Avid Radiopharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT02278367
What this trial is testing

Clinical Evaluation of Flortaucipir F 18

Who this might be right for
Alzheimer's DiseaseTraumatic Brain InjuryDepression
Avid Radiopharmaceuticals 179
Early research (Phase 1)Study completedNCT01564706
What this trial is testing

18F-AV-45 in Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 9
Early research (Phase 1)Study completedNCT04313127
What this trial is testing

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults

Who this might be right for
COVID-19
CanSino Biologics Inc. 108
Next Page